Clinical Trial Update: Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (RETAIN) evaluating risk-enabled therapy following initiation of neoadjuvant chemotherapy for bladder cancer; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Urothelial Carcinoma of the Bladder | Phase 2 | Status: ACTIVE_NOT_RECRUITING